Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

The company is struggling to make ends meet as it loses a major undisclosed client.

The PrIMAVeRa project develops a platform to evaluate how mAbs can combat AMR by reducing antibiotic use and providing ...

The 13 partners hope their research into establishing a universal test can help save time and money for therapy developers.

Because of NextCell’s algorithm that allows optimized donor choice for MSC production, its therapy could be completely ...

AAV8 gene therapy shows promise, but new scalable platform overcomes manufacturing challenges for consistent production.

As AI reshapes biotechnology, stakeholders are acting to establish governance to maintain safety and efficacy standards.

The legislature hopes to establish a domestic center of excellence for biopharmaceutical manufacturing.

We spoke with representatives from Anthony Nolan and eXmoor to discuss both their collaboration and the importance of ethical ...

Large pharmaceutical conglomerate Eli Lilly has announced plans to build a $6 billion manufacturing facility in Huntsville, Alabama. The site will focus on the production of small molecules and ...

Explore the latest news and expert commentary by Veerle d’Haenens, brought to you by the Contributor of BioProcess ...

Explore the latest news and expert commentary by Quentin Leclerc, brought to you by the Contributor of BioProcess International.